Allan L. Sherwin

4.4k total citations
92 papers, 3.1k citations indexed

About

Allan L. Sherwin is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Allan L. Sherwin has authored 92 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 33 papers in Psychiatry and Mental health and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Allan L. Sherwin's work include Epilepsy research and treatment (31 papers), Neuroscience and Neuropharmacology Research (27 papers) and Pharmacological Effects and Toxicity Studies (21 papers). Allan L. Sherwin is often cited by papers focused on Epilepsy research and treatment (31 papers), Neuroscience and Neuropharmacology Research (27 papers) and Pharmacological Effects and Toxicity Studies (21 papers). Allan L. Sherwin collaborates with scholars based in Canada, United States and New Zealand. Allan L. Sherwin's co-authors include N. M. van Gelder, T Rasmussen, Frédérick Andermann, Stephen J. Kish, F. Andermann, Michele Sammaritano, Ilo E. Leppik, André Olivier, L E Hokin and Linda V. Dansky and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Allan L. Sherwin

90 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan L. Sherwin Canada 30 1.3k 1.2k 877 851 266 92 3.1k
Denson G. Fujikawa United States 24 1.5k 1.1× 925 0.7× 897 1.0× 565 0.7× 185 0.7× 42 2.5k
Dixon M. Woodbury United States 30 1.3k 1.0× 573 0.5× 1.1k 1.2× 443 0.5× 257 1.0× 82 3.1k
William J. Logan Canada 36 1.3k 1.0× 1.2k 0.9× 1.1k 1.3× 638 0.7× 628 2.4× 94 4.3k
A. L. Johnson United Kingdom 29 1.0k 0.8× 2.2k 1.8× 587 0.7× 1.8k 2.1× 266 1.0× 41 3.9k
Eylert Brodtkorb Norway 35 740 0.6× 1.9k 1.5× 614 0.7× 1.5k 1.7× 473 1.8× 132 3.5k
David Holtzman United States 30 793 0.6× 294 0.2× 753 0.9× 488 0.6× 405 1.5× 94 3.3k
Faye S. Silverstein United States 49 1.7k 1.3× 994 0.8× 1.6k 1.8× 3.4k 4.0× 875 3.3× 125 6.7k
Marco Sifringer Germany 37 1.0k 0.8× 696 0.6× 1.4k 1.6× 1.6k 1.9× 401 1.5× 73 4.6k
Graeme J. Sills United Kingdom 35 1.7k 1.3× 2.6k 2.1× 894 1.0× 1.9k 2.3× 406 1.5× 95 4.4k
Silvia Balosso Italy 25 2.1k 1.6× 1.9k 1.5× 1.2k 1.4× 935 1.1× 278 1.0× 32 4.6k

Countries citing papers authored by Allan L. Sherwin

Since Specialization
Citations

This map shows the geographic impact of Allan L. Sherwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan L. Sherwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan L. Sherwin more than expected).

Fields of papers citing papers by Allan L. Sherwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan L. Sherwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan L. Sherwin. The network helps show where Allan L. Sherwin may publish in the future.

Co-authorship network of co-authors of Allan L. Sherwin

This figure shows the co-authorship network connecting the top 25 collaborators of Allan L. Sherwin. A scholar is included among the top collaborators of Allan L. Sherwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan L. Sherwin. Allan L. Sherwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kish, Stephen J., Paul S. Fitzmaurice, Isabelle Boileau, et al.. (2008). Brain serotonin transporter in human methamphetamine users. Psychopharmacology. 202(4). 649–661. 66 indexed citations
2.
Moszczyńska, Anna, Paul S. Fitzmaurice, Lee Cyn Ang, et al.. (2004). Brain antioxidant systems in human methamphetamine users. Journal of Neurochemistry. 89(6). 1396–1408. 65 indexed citations
3.
Sammaritano, Michele & Allan L. Sherwin. (2000). Effect of anticonvulsants on sleep.. PubMed. 54(5 Suppl 1). S16–24. 70 indexed citations
4.
Sherwin, Allan L.. (1999). Neuroactive Amino Acids in Focally Epileptic Human Brain: A Review. Neurochemical Research. 24(11). 1385–1395. 86 indexed citations
5.
Zifkin, Benjamin G., et al.. (1996). Historical Neurology and Neurosurgery George A. Savoy? Visionary Benefactor of Canadians with Epilepsy, and the History of the Savoy Foundation for Epilepsy. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 23(1). 80–82. 1 indexed citations
6.
Ross, Brian M., Allan L. Sherwin, & Stephen J. Kish. (1995). Multiple forms of the enzyme glycerophosphodiesterase are present in human brain. Lipids. 30(12). 1075–1081. 14 indexed citations
7.
Vernet, Olivier, et al.. (1992). Protein kinase C activity and subcellular distribution in rat brain following repeated electroconvulsive seizures. Experimental Neurology. 115(2). 297–301. 6 indexed citations
8.
Dubeau, François, Allan L. Sherwin, André Olivier, et al.. (1992). Excitatory Amino Acids Modulate Phosphoinositide Signal Transduction in Human Epileptic Neocortex. Epilepsia. 33(2). 255–262. 15 indexed citations
9.
Wolfe, L. S., et al.. (1989). Metabolism of Prostaglandin D2 by Human Cerebral Cortex into 9α, 11β‐Prostaglandin F2 by an Active NADPH‐Dependent 11‐Ketoreductase. Journal of Neurochemistry. 53(1). 64–70. 12 indexed citations
10.
Kish, Stephen J., André Olivier, François Dubeau, Yves Robitaille, & Allan L. Sherwin. (1988). Increased activity of choline acetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Research. 2(4). 227–231. 26 indexed citations
11.
Kish, Stephen J., et al.. (1988). Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex.. Journal of Neurology Neurosurgery & Psychiatry. 51(4). 552–556. 25 indexed citations
12.
Sammaritano, Michele, Frédérick Andermann, Denis Melanson, et al.. (1985). Prolonged Focal Cerebral Edema Associated with Partial Status Epilepticus. Epilepsia. 26(4). 334–339. 79 indexed citations
13.
Sherwin, Allan L., et al.. (1984). Enzyme changes in actively spiking areas of human epileptic cerebral cortex. Neurology. 34(7). 927–927. 57 indexed citations
14.
Gotman, Jean, Maria Grazia Marciani, P. Gloor, L. F. Quesney, & Allan L. Sherwin. (1984). EFFECTS OF WITHDRAWAL OF ANTICONVULSANT MEDICATION ON ICTAL AND INTERICTAL EEG ACTIVITY. Clinical Neuropharmacology. 7. S71–S71. 2 indexed citations
15.
Keene, D. L., Katherine Metrakos, Gordon V. Watters, & Allan L. Sherwin. (1982). Sodium Valproate in the Treatment of the Intractable Childhood Epileptic. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 9(3). 307–311. 1 indexed citations
16.
Odusote, Kayode & Allan L. Sherwin. (1981). A Simple, Direct Extraction Method for Gas-Liquid Chromatographic Determination of Valproic Acid in Plasma. Therapeutic Drug Monitoring. 3(1). 103–106. 8 indexed citations
17.
Armstrong, John, J. A. Lowden, & Allan L. Sherwin. (1977). Brain isoenzyme of creatine kinase. I. Purification of rabbit enzyme and production of specific antibodies.. Journal of Biological Chemistry. 252(10). 3105–3111. 21 indexed citations
18.
Leppik, Ilo E. & Allan L. Sherwin. (1975). Optimal combination therapy with dilantin and phenobarbital. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2(3). 330–331.
19.
Sherwin, Allan L., et al.. (1974). Effects of Age, Sex, Obesity, and Pregnancy on Plasma Diphenylhydantoin Levels. Epilepsia. 15(4). 507–521. 42 indexed citations
20.
Sherwin, Allan L., et al.. (1971). The rapid quantitative determination of diphenylhydantoin in plasma, serum, and whole blood of patients with epilepsy. Clinica Chimica Acta. 34(1). 97–103. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denson G. Fujikawa Breakdown of academic impact, for papers by Dixon M. Woodbury Breakdown of academic impact, for papers by William J. Logan Breakdown of academic impact, for papers by A. L. Johnson Breakdown of academic impact, for papers by Eylert Brodtkorb Breakdown of academic impact, for papers by David Holtzman Breakdown of academic impact, for papers by Faye S. Silverstein Breakdown of academic impact, for papers by Marco Sifringer Breakdown of academic impact, for papers by Graeme J. Sills Breakdown of academic impact, for papers by Silvia Balosso
Rankless by CCL
2026